These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9233563)

  • 1. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major.
    Ruf A; Pick M; Deutsch V; Patscheke H; Goldfarb A; Rachmilewitz EA; Guillin MC; Eldor A
    Br J Haematol; 1997 Jul; 98(1):51-6. PubMed ID: 9233563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of red blood cells "annexin V" and platelets "P-selectin" in patients with thalassemia.
    Mahdi ZN; Al-Mudallal SS; Hameed BM
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):15-18. PubMed ID: 30028953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in platelet activation associated with left ventricular assist system placement.
    Matsubayashi H; Fastenau DR; McIntyre JA
    J Heart Lung Transplant; 2000 May; 19(5):462-8. PubMed ID: 10808153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
    van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
    Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
    Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet membrane early activation markers during prolonged storage.
    Matsubayashi H; Weidner J; Miraglia CC; McIntyre JA
    Thromb Res; 1999 Feb; 93(4):151-60. PubMed ID: 10064270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of platelet activation markers after ischemic stroke.
    Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ
    Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated platelet-derived microparticles in thalassaemia.
    Pattanapanyasat K; Gonwong S; Chaichompoo P; Noulsri E; Lerdwana S; Sukapirom K; Siritanaratkul N; Fucharoen S
    Br J Haematol; 2007 Feb; 136(3):462-71. PubMed ID: 17278261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
    Joseph JE; Harrison P; Mackie IJ; Machin SJ
    Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.
    Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A
    Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with β-thalassemia following bone marrow transplantation.
    Klaihmon P; Vimonpatranon S; Noulsri E; Lertthammakiat S; Anurathapan U; Sirachainan N; Hongeng S; Pattanapanyasat K
    Ann Hematol; 2017 Oct; 96(10):1741-1747. PubMed ID: 28748286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets significantly modify procoagulant activities in haemophilia A.
    Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
    Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypercoagulable status in common Mediterranean β-thalassaemia mutations trait.
    Labib HA; Etewa RL; Atia H
    Int J Lab Hematol; 2015 Jun; 37(3):326-33. PubMed ID: 25179546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein.
    Takahashi Y; Fuda H; Yanai H; Akita H; Shuping H; Chiba H; Matsuno K
    Semin Thromb Hemost; 1998; 24(3):251-3. PubMed ID: 9701456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte phosphatidylserine exposure in β-thalassemia.
    Ibrahim HA; Fouda MI; Yahya RS; Abousamra NK; Abd Elazim RA
    Lab Hematol; 2014 Jun; 20(2):9-14. PubMed ID: 25000947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of platelet activation in ankylosing spondylitis.
    Wang F; Yan CG; Xiang HY; Xing T; Wang NS
    Clin Rheumatol; 2008 Jun; 27(6):767-9. PubMed ID: 18247078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PADGEM/GMP-140 expression on platelet membranes from homozygous beta thalassaemic patients.
    Del Principe D; Menichelli A; Di Giulio S; De Matteis W; Cianciulli P; Papa G
    Br J Haematol; 1993 May; 84(1):111-7. PubMed ID: 7687856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.